America’s Underinsurance Crisis in the Age of COVID-19
The COVID-19 pandemic has shone a light on the underinsurance crisis that has long kept millions of Americans on the precipice of financial disaster.

FDA’s approval of aducanumab may run against the bioethical principles of beneficence and non-maleficence.

Patients are understandably desperate, but their needs are best served by following the science, rather than lowering the standards for drugs.

The fiscal fragility of the Indian Health Service creates real problems for Native peoples.

There are a series of practical reforms that could readily improve the quality of nursing home care.

Family caregivers hold a critical role in the health care system and the economy, but do not receive adequate support and recognition.
